Attached files

file filename
EX-32.1 - EXHIBIT 32.1 FY2015 CEO 906 CERTIFICATION - BOSTON SCIENTIFIC CORPexhibit321-201510xk.htm
EX-21 - EXHIBIT 21 - FY2015 LIST OF SUBSIDIARIES DATED FEB 12, 2016 - BOSTON SCIENTIFIC CORPexhibit21-listofsubsidiari.htm
EX-31.2 - EXHIBIT 31.2 FY2015 CFO 302 CERTIFICATION - BOSTON SCIENTIFIC CORPexhibit312-201510xk.htm
EX-12 - EXHIBIT 12 - FY2015 RATIO OF EARNINGS TO FIXED CHARGES - BOSTON SCIENTIFIC CORPexhibit12-ratioofearningst.htm
EX-31.1 - EXHIBIT 31.1 - FY2015 CEO 302 CERTIFICATION - BOSTON SCIENTIFIC CORPexhibit311-201510xk.htm
EX-23 - EXHIBIT 23 - FY2015 AUDITOR CONSENT - BOSTON SCIENTIFIC CORPexhibit23-eyconsent201510xk.htm
10-K - 10-K - FY2015 - BOSTON SCIENTIFIC CORPa2015form10-k.htm
EX-10.5 - EXHIBIT 10.5 - FIRST AMENDMENT TO APRIL 10 2015 REVOLVER, DATED OCTOBER 23, 2015 - BOSTON SCIENTIFIC CORPex105_bscfirstamendmenttor.htm


EXHIBIT 32.2
 
 
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.
SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Boston Scientific Corporation (the “Company”) for the period ending December 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned Chief Financial Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that based on his knowledge:

 
(1)   
the Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and
 
(2)   
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Boston Scientific Corporation.


 
 
 
By:
/s/ Daniel J. Brennan
 
Daniel J. Brennan
 
 
 Executive Vice President and Chief Financial Officer
 
 
 
 
 
February 24, 2016